Please ensure Javascript is enabled for purposes of website accessibility

Emergent’s Baltimore facility cleared for deal sending COVID vaccines to Canada (access required)

Emergent BioSolutions' Baltimore facility was found to be compliant after an inspection concerning its production of the Johnson & Johnson COVID-19 vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *